Nanomedicine in the Treatment and Management of Alzheimer's Disease

<p>This book aims to discuss the various drug delivery approaches of neuroprotective medicines via nanoparticles such as enzymes monoclonal antibodies neurotrophic factors pharmaceutical drugs and nucleic acid-based medication to manage Alzheimer's disease.</p><p><i>Nanomedicine in the Treatment and Management of Alzheimer's Disease</i> investigates drug administration approaches either separately or in combination to improve neuroprotection in Alzheimer's disease. The book examines various novel therapeutic applications of nanomaterials in drug delivery for the central nervous system in Alzheimer's disease treatment. The book explores the role of nanoparticles in crossing the blood–brain barrier and blood-CSF barrier in the treatment and management of Alzheimer's disease. The authors also explain the nanoparticle-based delivery of therapeutic molecules including phytochemicals peptides siRNA enzymes and monoclonal antibodies in the treatment of Alzheimer's disease. Finally the book also discusses the various challenges and future perspectives of nanomedicine in the management of Alzheimer’s disease.</p><p>The book will help in bridging the gap of knowledge in neurosciences neurotherapeutics nanotechnology and nanomedicine domains. The book chapter may be useful to educators researchers legislators and medical professionals including pharmacologists biochemists corporate pharma R&D researchers neurologists and scientists involved in neurodegenerative diseases and nanomedicine.</p>